Leidos Holdings

LDOS · NYSE

$127.66+$1.61 (+1.28%)TodayMarket closed · Oct 20, 6:30 PM ET

Prev close $126.05

LDOS analyst rating

HoldConsensus of 14 analysts over the last 12 months. 36% rate it a buy.

Strong buy0
Buy5
Hold9
Underperform0
Sell0

12-month price target · 19 analysts

Average $158.22 (+23.9% upside)

Low: $132.91
Now: $127.66
High: $236.25

Upgrades and downgrades

The latest rating actions, newest first

LDOS analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 8, 2026	Downgrade	Overweight → Neutral	$160.00 → $142.00	63%
Citigroup	Oct 7, 2026	Maintains	Buy	$161.00 → $141.00	27%
Jefferies	Oct 6, 2026	Maintains	Hold	$145.00 → $130.00	55%
TD Cowen	Oct 6, 2026	Maintains	Hold	$135.00 → $130.00	63%
B of A Securities	Sep 18, 2026	Maintains	Neutral	$125.00 → $135.00	57%
Goldman Sachs	Aug 12, 2026	Maintains	Neutral	$152.00 → $132.00	49%
Citigroup	Aug 11, 2026	Maintains	Buy	$138.00 → $161.00	27%
TD Cowen	Aug 7, 2026	Maintains	Hold	$115.00 → $135.00	63%
UBS	Aug 5, 2026	Maintains	Neutral	$124.00 → $138.00	49%
BNP Paribas	Aug 5, 2026	Maintains	Outperform	$165.00 → $175.00	0%

The case for and against

Updated Oct 16, 2026

Bull case

Leidos Holdings is favored for its stronger-than-expected 1Q26 execution, with adjusted EPS of $3.13 versus $2.90 consensus and revenue of $4.4B rising 4% year over year, while the ~$2.4B Entrust acquisition lifted guidance and adds inorganic growth. Health remains a core support, as flat revenues still produced a 24.2% adjusted operating margin and elevated VA exam volumes should keep demand resilient, while defense exposure to air defense, hypersonics, and unmanned ships offers additional growth avenues. Although 2026 EBITDA margins are guided to mid-13% and the 0.8x book-to-bill shows some near-term backlog pressure, the 4% total backlog increase, 31% funded backlog gain, and roughly $9B of defense tech awards over the last 15 months support a constructive long-term view.

Bear case

Leidos Holdings is pressured by heavy dependence on U.S. government spending, where annual defense and agency funding can shift with congressional priorities, budget legislation, and Department of Veterans Affairs demand. It also faces meaningful operating and valuation risks from inflation, foreign exchange, interest rates, cyber threats, security disruptions, pension support dependence, and tax-rate exposure, while its defense profile can weigh on sustainability-minded investors. Although Entrust added $500 million to sales and $0.05 to adjusted EPS and guidance rose, management still expects 2Q26 to be the low point of the year, with risks from federal budget disruptions, slower contract ramp-up, staffing constraints, and pricing pressure.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.